PortfoliosLab logo
ALKS vs. GILD
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between ALKS and GILD is 0.39, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Performance

ALKS vs. GILD - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Alkermes plc (ALKS) and Gilead Sciences, Inc. (GILD). The values are adjusted to include any dividend payments, if applicable.

0.00%5,000.00%10,000.00%15,000.00%20,000.00%25,000.00%December2025FebruaryMarchAprilMay
161.33%
21,771.66%
ALKS
GILD

Key characteristics

Sharpe Ratio

ALKS:

0.78

GILD:

2.21

Sortino Ratio

ALKS:

1.35

GILD:

3.00

Omega Ratio

ALKS:

1.16

GILD:

1.38

Calmar Ratio

ALKS:

0.34

GILD:

1.86

Martin Ratio

ALKS:

3.34

GILD:

10.97

Ulcer Index

ALKS:

7.81%

GILD:

5.05%

Daily Std Dev

ALKS:

33.57%

GILD:

25.92%

Max Drawdown

ALKS:

-96.15%

GILD:

-70.82%

Current Drawdown

ALKS:

-69.02%

GILD:

-15.81%

Fundamentals

Market Cap

ALKS:

$5.24B

GILD:

$128.00B

EPS

ALKS:

$2.10

GILD:

$4.76

PE Ratio

ALKS:

14.95

GILD:

21.60

PEG Ratio

ALKS:

-1.06K

GILD:

0.22

PS Ratio

ALKS:

3.46

GILD:

4.45

PB Ratio

ALKS:

3.58

GILD:

6.77

Total Revenue (TTM)

ALKS:

$1.51B

GILD:

$28.73B

Gross Profit (TTM)

ALKS:

$1.33B

GILD:

$23.07B

EBITDA (TTM)

ALKS:

$447.71M

GILD:

$9.89B

Returns By Period

In the year-to-date period, ALKS achieves a 5.63% return, which is significantly lower than GILD's 7.01% return. Over the past 10 years, ALKS has underperformed GILD with an annualized return of -6.52%, while GILD has yielded a comparatively higher 2.83% annualized return.


ALKS

YTD

5.63%

1M

7.77%

6M

4.87%

1Y

26.06%

5Y*

15.23%

10Y*

-6.52%

GILD

YTD

7.01%

1M

-4.87%

6M

1.82%

1Y

56.88%

5Y*

9.19%

10Y*

2.83%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

ALKS vs. GILD — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ALKS
The Risk-Adjusted Performance Rank of ALKS is 7575
Overall Rank
The Sharpe Ratio Rank of ALKS is 7979
Sharpe Ratio Rank
The Sortino Ratio Rank of ALKS is 7474
Sortino Ratio Rank
The Omega Ratio Rank of ALKS is 7070
Omega Ratio Rank
The Calmar Ratio Rank of ALKS is 6868
Calmar Ratio Rank
The Martin Ratio Rank of ALKS is 8181
Martin Ratio Rank

GILD
The Risk-Adjusted Performance Rank of GILD is 9494
Overall Rank
The Sharpe Ratio Rank of GILD is 9797
Sharpe Ratio Rank
The Sortino Ratio Rank of GILD is 9494
Sortino Ratio Rank
The Omega Ratio Rank of GILD is 9292
Omega Ratio Rank
The Calmar Ratio Rank of GILD is 9292
Calmar Ratio Rank
The Martin Ratio Rank of GILD is 9595
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

ALKS vs. GILD - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Alkermes plc (ALKS) and Gilead Sciences, Inc. (GILD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The current ALKS Sharpe Ratio is 0.78, which is lower than the GILD Sharpe Ratio of 2.21. The chart below compares the historical Sharpe Ratios of ALKS and GILD, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-0.500.000.501.001.502.002.503.00December2025FebruaryMarchAprilMay
0.78
2.21
ALKS
GILD

Dividends

ALKS vs. GILD - Dividend Comparison

ALKS has not paid dividends to shareholders, while GILD's dividend yield for the trailing twelve months is around 3.16%.


TTM2024202320222021202020192018201720162015
ALKS
Alkermes plc
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
GILD
Gilead Sciences, Inc.
3.16%3.33%3.70%3.40%3.91%4.67%3.88%3.65%2.90%2.57%1.27%

Drawdowns

ALKS vs. GILD - Drawdown Comparison

The maximum ALKS drawdown since its inception was -96.15%, which is greater than GILD's maximum drawdown of -70.82%. Use the drawdown chart below to compare losses from any high point for ALKS and GILD. For additional features, visit the drawdowns tool.


-80.00%-60.00%-40.00%-20.00%0.00%December2025FebruaryMarchAprilMay
-69.02%
-15.81%
ALKS
GILD

Volatility

ALKS vs. GILD - Volatility Comparison

Alkermes plc (ALKS) has a higher volatility of 12.99% compared to Gilead Sciences, Inc. (GILD) at 9.98%. This indicates that ALKS's price experiences larger fluctuations and is considered to be riskier than GILD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


4.00%6.00%8.00%10.00%12.00%14.00%December2025FebruaryMarchAprilMay
12.99%
9.98%
ALKS
GILD

Financials

ALKS vs. GILD - Financials Comparison

This section allows you to compare key financial metrics between Alkermes plc and Gilead Sciences, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.002.00B4.00B6.00B8.00B20212022202320242025
306.51M
6.67B
(ALKS) Total Revenue
(GILD) Total Revenue
Values in USD except per share items

ALKS vs. GILD - Profitability Comparison

The chart below illustrates the profitability comparison between Alkermes plc and Gilead Sciences, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

60.0%70.0%80.0%90.0%100.0%20212022202320242025
100.0%
85.6%
(ALKS) Gross Margin
(GILD) Gross Margin
ALKS - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Alkermes plc reported a gross profit of 306.51M and revenue of 306.51M. Therefore, the gross margin over that period was 100.0%.

GILD - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Gilead Sciences, Inc. reported a gross profit of 5.71B and revenue of 6.67B. Therefore, the gross margin over that period was 85.6%.

ALKS - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Alkermes plc reported an operating income of 13.79M and revenue of 306.51M, resulting in an operating margin of 4.5%.

GILD - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Gilead Sciences, Inc. reported an operating income of 3.15B and revenue of 6.67B, resulting in an operating margin of 47.2%.

ALKS - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Alkermes plc reported a net income of 22.46M and revenue of 306.51M, resulting in a net margin of 7.3%.

GILD - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Gilead Sciences, Inc. reported a net income of 1.32B and revenue of 6.67B, resulting in a net margin of 19.7%.